The LECKEY MyWay Pedal by Sunrise Medical has been named a 2025 Mobility Management Product Award winner in the Gait Trainers category by Mobility Management.
The Mobility Management Product Awards program honors outstanding product development in Complex Rehab Technology (CRT) and accessibility. Rachel Magill, Digital Marketing Lead at Sunrise Medical, sat down with Mobility Management to share more about the LECKEY MyWay Pedal solution and her thoughts on the future of the industry. To learn more about the Mobility Management Product Awards and view all of this year’s winners, visit https://mobilitymgmt.com/product-awards/.
MM: Tell us about the LECKEY MyWay Pedal, including its top features and benefits.
Magill: The MyWay Pedal is a revolutionary elliptical trainer which helps improve strength and functional stepping ability by providing opportunity for movement in a sensori-motor pattern which is similar to gait.
When learning to walk, children often struggle to gain sufficient lower limb strength and develop a clear reciprocal stepping pattern. The LECKEY MyWay Pedal:
- Facilitates movement in an upright, extended position, working muscles where they are weaker rather than in a flexed position, like cycling
- Targets and strengthens anti-gravity muscles
- Elliptical action provides a sensori-motor experience similar to gait
It includes a groundbreaking Android app that supports therapists and families in goal-setting and recording outcome measures.
MM: In designing this product, what were the top priorities of your design team and engineers?
Magill: Our team’s top priorities were to encourage activity and movement in an upright, extended position in children with additional needs.
MM: Who and/or what were the inspirations for your winning product’s functionality, features and design elements?
Magill: What inspired our team was the need to create a product that would help children overcome struggles, such as learning to walk, gaining sufficient lower limb strength, and developing a clear, reciprocal stepping pattern.
MM: Who benefits from your product? Can you offer a “typical” client profile?
Magill: The MyWay Pedal benefits children with mobility impairments who require support for active lower-limb strengthening, reciprocal movement practice, and improved lower-limb alignment. A typical user may be a child with cerebral palsy (GMFCS III–V), a developmental delay, a neuromuscular condition, or an acquired brain injury.
It can support younger children who have not yet developed a consistent stepping pattern and need frequent practice to build motor pathways, as well as children following interventions such as orthopedic surgery, botulinum toxin injections, or selective dorsal rhizotomy who require targeted muscle strengthening. It is not suitable for children with unstable or painful lower-limb pathology, severe range-of-motion limitations, or medical conditions that prevent safe cardiovascular effort or upright positioning. The MyWay Pedal offers a safe and motivating way for children with varied needs to remain active while working toward their therapy goals.
MM: Does your winning product offer adjustability or customizability for the different needs of different clients?
Magill: The MyWay Pedal is suitable for children ages 4-16 of moderate to complex needs. It attaches to the MyWay+ frame in size 2 or 3 and can therefore accommodate a growing child as they upgrade their frame.
The MyWay Pedal accommodated varying needs as it can be used:
- Passively — at first for those who struggle to initiate any stepping
- Actively — with the ankle straps in place
- Free — with the ankle straps removed for the hardest workout
MM: How does your winning product optimize independence, function, safety, confidence, success with everyday goals, etc., for its consumers?
Magill: Whereas conventional cycling reinforces a flexed posture, the MyWay Pedal does the opposite by targeting and strengthening the big anti-gravity muscles (calf, quads, hamstrings) at their end-of-range where they are weaker. This reduces the risk of hip and knee contractures developing and limits the potential for deterioration in standing and walking ability.
The MyWay Pedal facilitates an elliptical action, thus providing a sensori-motor experience similar to gait. Unlike the circular motion of cycling, the elliptical pedaling with longer fore/back movement, provides an extended stretch of the lower limbs. This, in turn, improves loading around the hip to aid joint development.
MM: What funding options are available for this product?
Magill: The MyWay Pedal is an accessory to the MyWay+ walking frame. The MyWay+ is often submitted to insurance under the HCPCS code E8000 for a pediatric posterior gait trainer. The pedal is not coded, but uses the miscellaneous code E1399, and has been funded by some insurance companies where the physical therapist (PT) has argued the product’s therapeutic benefits. The decision on funding route is one taken by the ATP, PT and family.
MM: What makes a product or service a Mobility Management Product Award winner? What advice do you have for future entrants?
Magill: The Mobility Management Product Awards program honors outstanding product development in Complex Rehab Technology and accessibility. At Leckey, our world class team strive for continuous learning and innovation by utilizing state of the art processes and techniques to push boundaries and deliver on our goals.
